APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nifedipine Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchNifedipine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nifedipine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nifedipine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nifedipine market include Actavis, Bayer, Honglin Pharmaceutical, Huanghai, Pfizer, Lifeon Pharmaceutical, Teva, Simcere and Shyndec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine Segment by Company

Actavis

Bayer

Honglin Pharmaceutical

Huanghai

Pfizer

Lifeon Pharmaceutical

Teva

Simcere

Shyndec

Yabao

ApicHope

EASEHEAL Pharmaceutical

Nifedipine Segment by Type

Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets

Nifedipine Segment by Application

Hypertension

Heart Disease

Other

Nifedipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nifedipine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nifedipine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nifedipine significant trends, drivers, influence factors in global and regions.

6. To analyze Nifedipine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nifedipine industry.

Chapter 3: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nifedipine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nifedipine Industry Trends Table 2. Nifedipine Industry Drivers Table 3. Nifedipine Industry Opportunities and Challenges Table 4. Nifedipine Industry Restraints Table 5. Global Nifedipine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nifedipine Revenue Share by Company (2021-2026) Table 7. Global Nifedipine Sales Volume by Company (tons) & (2021-2026) Table 8. Global Nifedipine Sales Volume Share by Company (2021-2026) Table 9. Global Nifedipine Average Price (US$/kg) of Company (2021-2026) Table 10. Global Nifedipine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nifedipine Key Company Manufacturing Base & Headquarters Table 12. Global Nifedipine Company, Product Type & Application Table 13. Global Nifedipine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nifedipine Controlled Release Tablets Table 18. Significant Companies of Nifedipine Extended Action Tablets Table 19. Global Nifedipine Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Nifedipine Sales Volume by Type (2021-2026) & (tons) Table 21. Global Nifedipine Sales Volume by Type (2027-2032) & (tons) Table 22. Global Nifedipine Sales Volume Share by Type (2021-2026) Table 23. Global Nifedipine Sales Volume Share by Type (2027-2032) Table 24. Global Nifedipine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nifedipine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nifedipine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nifedipine Sales Value Share by Type (2021-2026) Table 28. Global Nifedipine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hypertension Table 30. Significant Companies of Heart Disease Table 31. Significant Companies of Other Table 32. Global Nifedipine Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 33. Global Nifedipine Sales Volume by Application (2021-2026) & (tons) Table 34. Global Nifedipine Sales Volume by Application (2027-2032) & (tons) Table 35. Global Nifedipine Sales Volume Share by Application (2021-2026) Table 36. Global Nifedipine Sales Volume Share by Application (2027-2032) Table 37. Global Nifedipine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nifedipine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Nifedipine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Nifedipine Sales Value Share by Application (2021-2026) Table 41. Global Nifedipine Sales Value Share by Application (2027-2032) Table 42. Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 43. Global Nifedipine Sales by Region (2021-2026) & (tons) Table 44. Global Nifedipine Sales Market Share by Region (2021-2026) Table 45. Global Nifedipine Sales by Region (2027-2032) & (tons) Table 46. Global Nifedipine Sales Market Share by Region (2027-2032) Table 47. Global Nifedipine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nifedipine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Nifedipine Sales Value Share by Region (2021-2026) Table 50. Global Nifedipine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Nifedipine Sales Value Share by Region (2027-2032) Table 52. Global Nifedipine Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Nifedipine Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Global Nifedipine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Nifedipine Sales by Country (2021-2026) & (tons) Table 57. Global Nifedipine Sales Market Share by Country (2021-2026) Table 58. Global Nifedipine Sales by Country (2027-2032) & (tons) Table 59. Global Nifedipine Sales Market Share by Country (2027-2032) Table 60. Global Nifedipine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Nifedipine Sales Value Market Share by Country (2021-2026) Table 62. Global Nifedipine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Nifedipine Sales Value Market Share by Country (2027-2032) Table 64. Actavis Company Information Table 65. Actavis Business Overview Table 66. Actavis Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Actavis Nifedipine Product Portfolio Table 68. Actavis Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Bayer Nifedipine Product Portfolio Table 73. Bayer Recent Development Table 74. Honglin Pharmaceutical Company Information Table 75. Honglin Pharmaceutical Business Overview Table 76. Honglin Pharmaceutical Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Honglin Pharmaceutical Nifedipine Product Portfolio Table 78. Honglin Pharmaceutical Recent Development Table 79. Huanghai Company Information Table 80. Huanghai Business Overview Table 81. Huanghai Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Huanghai Nifedipine Product Portfolio Table 83. Huanghai Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Pfizer Nifedipine Product Portfolio Table 88. Pfizer Recent Development Table 89. Lifeon Pharmaceutical Company Information Table 90. Lifeon Pharmaceutical Business Overview Table 91. Lifeon Pharmaceutical Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Lifeon Pharmaceutical Nifedipine Product Portfolio Table 93. Lifeon Pharmaceutical Recent Development Table 94. Teva Company Information Table 95. Teva Business Overview Table 96. Teva Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Teva Nifedipine Product Portfolio Table 98. Teva Recent Development Table 99. Simcere Company Information Table 100. Simcere Business Overview Table 101. Simcere Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Simcere Nifedipine Product Portfolio Table 103. Simcere Recent Development Table 104. Shyndec Company Information Table 105. Shyndec Business Overview Table 106. Shyndec Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. Shyndec Nifedipine Product Portfolio Table 108. Shyndec Recent Development Table 109. Yabao Company Information Table 110. Yabao Business Overview Table 111. Yabao Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Yabao Nifedipine Product Portfolio Table 113. Yabao Recent Development Table 114. ApicHope Company Information Table 115. ApicHope Business Overview Table 116. ApicHope Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 117. ApicHope Nifedipine Product Portfolio Table 118. ApicHope Recent Development Table 119. EASEHEAL Pharmaceutical Company Information Table 120. EASEHEAL Pharmaceutical Business Overview Table 121. EASEHEAL Pharmaceutical Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 122. EASEHEAL Pharmaceutical Nifedipine Product Portfolio Table 123. EASEHEAL Pharmaceutical Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Nifedipine Distributors List Table 127. Nifedipine Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Nifedipine Product Image Figure 2. Global Nifedipine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Sales (2021-2032) & (tons) Figure 5. Global Nifedipine Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Nifedipine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nifedipine Controlled Release Tablets Image Figure 10. Nifedipine Extended Action Tablets Image Figure 11. Global Nifedipine Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Nifedipine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nifedipine Sales Volume Share by Type (2021-2032) Figure 14. Global Nifedipine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nifedipine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nifedipine Sales Value Share by Type (2021-2032) Figure 17. Hypertension Image Figure 18. Heart Disease Image Figure 19. Other Image Figure 20. Global Nifedipine Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 21. Global Nifedipine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Nifedipine Sales Volume Share by Application (2021-2032) Figure 23. Global Nifedipine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nifedipine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nifedipine Sales Value Share by Application (2021-2032) Figure 26. Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 27. Global Nifedipine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nifedipine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nifedipine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Nifedipine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Nifedipine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Nifedipine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Nifedipine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Nifedipine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Nifedipine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Nifedipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Nifedipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Nifedipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Nifedipine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Nifedipine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Action Tablets
Applications
  • Hypertension
  • Heart Disease
  • Other
Companies covered
  • Actavis
  • Bayer
  • Honglin Pharmaceutical
  • Huanghai
  • Pfizer
  • Lifeon Pharmaceutical
  • Teva
  • Simcere
  • Shyndec
  • Yabao
  • ApicHope
  • EASEHEAL Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine Sales Value (2021-2032)
  4. 1.2.2 Global Nifedipine Sales Volume (2021-2032)
  5. 1.2.3 Global Nifedipine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nifedipine Market Dynamics
  1. 2.1 Nifedipine Industry Trends
  2. 2.2 Nifedipine Industry Drivers
  3. 2.3 Nifedipine Industry Opportunities and Challenges
  4. 2.4 Nifedipine Industry Restraints
3 Nifedipine Market by Company
  1. 3.1 Global Nifedipine Company Revenue Ranking in 2025
  2. 3.2 Global Nifedipine Revenue by Company (2021-2026)
  3. 3.3 Global Nifedipine Sales Volume by Company (2021-2026)
  4. 3.4 Global Nifedipine Average Price by Company (2021-2026)
  5. 3.5 Global Nifedipine Company Ranking (2024-2026)
  6. 3.6 Global Nifedipine Company Manufacturing Base and Headquarters
  7. 3.7 Global Nifedipine Company Product Type and Application
  8. 3.8 Global Nifedipine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nifedipine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nifedipine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nifedipine Market by Type
  1. 4.1 Nifedipine Type Introduction
  2. 4.1.1 Nifedipine Controlled Release Tablets
  3. 4.1.2 Nifedipine Extended Action Tablets
  4. 4.2 Global Nifedipine Sales Volume by Type
  5. 4.2.1 Global Nifedipine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nifedipine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nifedipine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nifedipine Sales Value by Type
  9. 4.3.1 Global Nifedipine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nifedipine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nifedipine Sales Value Share by Type (2021-2032)
5 Nifedipine Market by Application
  1. 5.1 Nifedipine Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Heart Disease
  4. 5.1.3 Other
  5. 5.2 Global Nifedipine Sales Volume by Application
  6. 5.2.1 Global Nifedipine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nifedipine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nifedipine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nifedipine Sales Value by Application
  10. 5.3.1 Global Nifedipine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nifedipine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nifedipine Sales Value Share by Application (2021-2032)
6 Nifedipine Regional Sales and Value Analysis
  1. 6.1 Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine Sales by Region: 2021-2026
  4. 6.2.2 Global Nifedipine Sales by Region (2027-2032)
  5. 6.3 Global Nifedipine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nifedipine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nifedipine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nifedipine Sales Value by Region (2027-2032)
  9. 6.5 Global Nifedipine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nifedipine Sales Value (2021-2032)
  12. 6.6.2 North America Nifedipine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nifedipine Sales Value (2021-2032)
  15. 6.7.2 Europe Nifedipine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nifedipine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nifedipine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nifedipine Sales Value (2021-2032)
  21. 6.9.2 South America Nifedipine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nifedipine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nifedipine Sales Value Share by Country, 2025 VS 2032
7 Nifedipine Country-level Sales and Value Analysis
  1. 7.1 Global Nifedipine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nifedipine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nifedipine Sales by Country (2021-2032)
  4. 7.3.1 Global Nifedipine Sales by Country (2021-2026)
  5. 7.3.2 Global Nifedipine Sales by Country (2027-2032)
  6. 7.4 Global Nifedipine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nifedipine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nifedipine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nifedipine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nifedipine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nifedipine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nifedipine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nifedipine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nifedipine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nifedipine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nifedipine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nifedipine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nifedipine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nifedipine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nifedipine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nifedipine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nifedipine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nifedipine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nifedipine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nifedipine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nifedipine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nifedipine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nifedipine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nifedipine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nifedipine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nifedipine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nifedipine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nifedipine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nifedipine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nifedipine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nifedipine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nifedipine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nifedipine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nifedipine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nifedipine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nifedipine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nifedipine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nifedipine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nifedipine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nifedipine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nifedipine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nifedipine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nifedipine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nifedipine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nifedipine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nifedipine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nifedipine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nifedipine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nifedipine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nifedipine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nifedipine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nifedipine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nifedipine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nifedipine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nifedipine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nifedipine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nifedipine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nifedipine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nifedipine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nifedipine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nifedipine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nifedipine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nifedipine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nifedipine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nifedipine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nifedipine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nifedipine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nifedipine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nifedipine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nifedipine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nifedipine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nifedipine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nifedipine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nifedipine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nifedipine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nifedipine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nifedipine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nifedipine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nifedipine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nifedipine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nifedipine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nifedipine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nifedipine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nifedipine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nifedipine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nifedipine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nifedipine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Nifedipine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Nifedipine Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Nifedipine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Nifedipine Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Honglin Pharmaceutical
  14. 8.3.1 Honglin Pharmaceutical Company Information
  15. 8.3.2 Honglin Pharmaceutical Business Overview
  16. 8.3.3 Honglin Pharmaceutical Nifedipine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Honglin Pharmaceutical Nifedipine Product Portfolio
  18. 8.3.5 Honglin Pharmaceutical Recent Developments
  19. 8.4 Huanghai
  20. 8.4.1 Huanghai Company Information
  21. 8.4.2 Huanghai Business Overview
  22. 8.4.3 Huanghai Nifedipine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Huanghai Nifedipine Product Portfolio
  24. 8.4.5 Huanghai Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Nifedipine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Nifedipine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Lifeon Pharmaceutical
  32. 8.6.1 Lifeon Pharmaceutical Company Information
  33. 8.6.2 Lifeon Pharmaceutical Business Overview
  34. 8.6.3 Lifeon Pharmaceutical Nifedipine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
  36. 8.6.5 Lifeon Pharmaceutical Recent Developments
  37. 8.7 Teva
  38. 8.7.1 Teva Company Information
  39. 8.7.2 Teva Business Overview
  40. 8.7.3 Teva Nifedipine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Teva Nifedipine Product Portfolio
  42. 8.7.5 Teva Recent Developments
  43. 8.8 Simcere
  44. 8.8.1 Simcere Company Information
  45. 8.8.2 Simcere Business Overview
  46. 8.8.3 Simcere Nifedipine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Simcere Nifedipine Product Portfolio
  48. 8.8.5 Simcere Recent Developments
  49. 8.9 Shyndec
  50. 8.9.1 Shyndec Company Information
  51. 8.9.2 Shyndec Business Overview
  52. 8.9.3 Shyndec Nifedipine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shyndec Nifedipine Product Portfolio
  54. 8.9.5 Shyndec Recent Developments
  55. 8.10 Yabao
  56. 8.10.1 Yabao Company Information
  57. 8.10.2 Yabao Business Overview
  58. 8.10.3 Yabao Nifedipine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yabao Nifedipine Product Portfolio
  60. 8.10.5 Yabao Recent Developments
  61. 8.11 ApicHope
  62. 8.11.1 ApicHope Company Information
  63. 8.11.2 ApicHope Business Overview
  64. 8.11.3 ApicHope Nifedipine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ApicHope Nifedipine Product Portfolio
  66. 8.11.5 ApicHope Recent Developments
  67. 8.12 EASEHEAL Pharmaceutical
  68. 8.12.1 EASEHEAL Pharmaceutical Company Information
  69. 8.12.2 EASEHEAL Pharmaceutical Business Overview
  70. 8.12.3 EASEHEAL Pharmaceutical Nifedipine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
  72. 8.12.5 EASEHEAL Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine Value Chain Analysis
  2. 9.1.1 Nifedipine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine Sales Mode & Process
  6. 9.2 Nifedipine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine Distributors
  9. 9.2.3 Nifedipine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst